Cargando…
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
Dentritic cell (DC)-based cancer immunotherapy faces challenges in both efficacy and practicality. However, DC-based vaccination requires multiple injections and elaborates ex vivo manipulation, which substantially limits their use. Therefore, we sought to develop a chitosan nanoparticle (CH-NP)-bas...
Autores principales: | Han, Hee Dong, Byeon, Yeongseon, Jang, Jong-Hwa, Jeon, Hat Nim, Kim, Ga Hee, Kim, Min Gi, Pack, Chan-Gi, Kang, Tae Heung, Jung, In Duk, Lim, Yong Taik, Lee, Young Joo, Lee, Jeong-Won, Shin, Byung Cheol, Ahn, Hyung Jun, Sood, Anil K., Park, Yeong-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133713/ https://www.ncbi.nlm.nih.gov/pubmed/27910914 http://dx.doi.org/10.1038/srep38348 |
Ejemplares similares
-
GM-CSF-loaded chitosan hydrogel as an immunoadjuvant enhances antigen-specific immune responses with reduced toxicity
por: Noh, Kyung Hee, et al.
Publicado: (2014) -
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
por: Kim, Ga Hee, et al.
Publicado: (2018) -
Enhanced localization of anticancer drug in tumor tissue using polyethylenimine-conjugated cationic liposomes
por: Han, Hee Dong, et al.
Publicado: (2014) -
Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy
por: Han, Hee Dong, et al.
Publicado: (2016) -
Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
por: Kwak, Min Seob, et al.
Publicado: (2018)